Automated Protein Data Filtration for Drug Development

The patent creates a computational copy of the manual determination process through machine learning models that replicate protein impact analysis. The system uses trained classifiers to automatically analyze biomedical literature and determine protein expression impacts, replacing time-consuming manual laboratory and computational techniques with an automated digital twin of the analysis process.

The patent replaces manual mechanical processes (laboratory techniques and human computational analysis) with an automated electronic system. The machine learning-based platform substitutes human experts' manual work with algorithmic processing, using electronic data extraction and classification to determine protein impacts without physical laboratory intervention.

The patent introduces an intermediary processing layer between the scattered biomedical data and the final analysis results. The system uses natural language processing and machine learning classifiers as intermediaries to automatically organize, filter, and structure unorganized biomedical literature data, transforming scattered text into structured protein impact information without manual intervention.

The patent transforms the state of biomedical data from unorganized text to structured information by changing key parameters. The system applies text extraction, classification, and filtering operations that convert raw literature data into organized protein impact assessments, fundamentally changing the organizational state of the data from chaotic to structured.

The patent implements a self-updating system that automatically monitors and processes new biomedical data as it becomes available. The machine learning platform continuously self-updates by ingesting new literature, automatically validating and integrating current protein-disease relationships without requiring manual system reconfiguration or expert intervention for each update cycle.

The system incorporates feedback mechanisms where the machine learning models continuously learn from new biomedical literature and update their predictions accordingly. The platform uses feedback from newly published research to refine and update protein impact assessments, ensuring current accuracy through automated continuous learning and adaptation.